Jump Financial’s Immuneering IMRX Stock Holding History
Bought
Maintained
Sold
Other funds holding IMRX
DA
Jump Financial's IMRX Position: Q3 2026 in Review
Jump Financial sold out of Immuneering (IMRX) in Q3 2026, closing a stake of 12,700 shares — an estimated $63.4K sold.
Jump Financial first reported a position in IMRX in Q1 2022 and held it in 3 quarters. The position peaked at $125K in Q1 2022. 131 funds tracked by Wall St. Rank hold IMRX as of Q3 2026.
- Jump Financial reported no remaining Immuneering position as of Q3 2026 after selling out during the quarter.
- Jump Financial sold 12,700 Immuneering shares in Q3 2026, an estimated $63.4K.
- Jump Financial first reported a position in Immuneering in Q1 2022 and held it in 3 quarters.
- Jump Financial's Immuneering position peaked at $125K in Q1 2022.
- 131 funds tracked by Wall St. Rank held Immuneering as of Q3 2026.
Based on Jump Financial's 13F filing for Q3 2026, filed 13 Nov 2026.